| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARTICLE |
Act Together to Induce the Cellular Inhibitor of Apoptosis-2 Gene and Prevent Apoptosis in a Variety of Cell Types
Departments of Inflammatory Diseases Research (J.C.W., R.L.H., E.A.A.) and Biotechnology (R.M.H., P.M.C., J.K.M., T.C.B.), Bristol-Myers Squibb Pharma, Wilmington, Delaware 19880
Address all correspondence and requests for reprints to: Jeffrey C. Webster, Transtech Pharma, 4170 Mendehall Oaks Parkway, Suite 110, High Point, North Carolina 27265. E-mail: jwebster{at}ttpharma.com.
Using microarray technology, we analyzed 12,000 genes for regulation by TNF-
and the synthetic glucocorticoid, dexamethasone, in the human lung epithelial cell line, A549. Only one gene was induced by both agents, the cellular inhibitor of apoptosis 2 (c-IAP2), which was induced 17-fold and 5-fold by TNF-
at 2 h and 24 h, respectively, and increased 14-fold and 9-fold by dexamethasone at 2 h and 24 h, respectively. The combination of the two agents together led to an additive increase (34-fold) at 2 h and a more than additive effect (36-fold) at 24 h. The human c-IAP2 promoter contains two nuclear factor (NF)-
B sites that have been shown to be required for transcriptional activation by TNF-
. To test whether glucocorticoids regulate the c-IAP2 gene at the level of the promoter, a reporter vector containing 947 bases upstream of the start site of transcription of the human c-IAP2 promoter was linked to luciferase [IAP(-947+54)-LUC] and transfected into A549 cells. Dexamethasone and TNF-
each induced reporter activity, whereas the combination of the two agents led to greater induction of luciferase than either one alone. Truncation of the promoter region containing a putative glucocorticoid response element (GRE) at -515 [IAP(-395+54)-LUC] or mutation of the GRE in the context of the natural promoter [IAP(-947+54mutGRE)-LUC] resulted in a loss of dexamethasone-mediated induction of reporter activity. Although the functional NF-
B sites were retained in the truncated and mutant c-IAP2 promoter constructs, dexamethasone did not inhibit the TNF-
induction of luciferase activity, indicating that GR repression through the NF-
B sites did not occur. Regulation of the c-IAP2 gene is therefore unique, as GR and NF-
B signaling pathways are usually mutually antagonistic, not cooperative. Treatment of A549 cells with TNF-
and/or dexamethasone had no effect on cell death, but the two agents were able to inhibit interferon-
/anti-FAS antibody-mediated apoptosis. In human glioblastoma A172 cells, TNF-
and dexamethasone together elicited a greater than additive increase in c-IAP2 mRNA levels and also inhibited anti-FAS antibody-mediated A172 cell apoptosis. In contrast, in human CEM-C7 leukemic T cells, whereas TNF-
and dexamethasone treatment also led to an increase in c-IAP2 mRNA, the two agents were able to induce apoptosis on their own. However, TNF-
and dexamethasone were also able to blunt anti-FAS-induced apoptosis in the T cells. These data indicate that the induction of the antiapoptotic protein, c-IAP2, by glucocorticoids and TNF-
correlates with the ability of these agents to inhibit apoptosis in a variety of cell types.
This article has been cited by other articles:
![]() |
R. Newton and N. S. Holden Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor? Mol. Pharmacol., October 1, 2007; 72(4): 799 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fuentes, K. C. Tran, P. Luthra, M. N. Teng, and B. He Function of the Respiratory Syncytial Virus Small Hydrophobic Protein J. Virol., August 1, 2007; 81(15): 8361 - 8366. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sola, J. D. Amaral, P. M. Borralho, R. M. Ramalho, R. E. Castro, M. M. Aranha, C. J. Steer, and C. M. P. Rodrigues Functional Modulation of Nuclear Steroid Receptors by Tauroursodeoxycholic Acid Reduces Amyloid {beta}-Peptide-Induced Apoptosis Mol. Endocrinol., October 1, 2006; 20(10): 2292 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Trujillo, M.-J. Lee, S. Sullivan, J. Feng, S. H. Schneider, A. S. Greenberg, and S. K. Fried Tumor Necrosis Factor {alpha} and Glucocorticoid Synergistically Increase Leptin Production in Human Adipose Tissue: Role for p38 Mitogen-Activated Protein Kinase J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1484 - 1490. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mishra, J. P. Mishra, K. Gee, D. C. McManus, E. C. LaCasse, and A. Kumar Distinct Role of Calmodulin and Calmodulin-dependent Protein Kinase-II in Lipopolysaccharide and Tumor Necrosis Factor-{alpha}-mediated Suppression of Apoptosis and Antiapoptotic c-IAP2 Gene Expression in Human Monocytic Cells J. Biol. Chem., November 11, 2005; 280(45): 37536 - 37546. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Regala, C. Weems, L. Jamieson, J. A. Copland, E. A. Thompson, and A. P. Fields Atypical Protein Kinase C{iota} Plays a Critical Role in Human Lung Cancer Cell Growth and Tumorigenicity J. Biol. Chem., September 2, 2005; 280(35): 31109 - 31115. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B. Runnebaum and A. Bruning Glucocorticoids Inhibit Cell Death in Ovarian Cancer and Up-regulate Caspase Inhibitor cIAP2 Clin. Cancer Res., September 1, 2005; 11(17): 6325 - 6332. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z Alourfi, R P Donn, A Stevens, A Berry, A McMaster, and D W Ray Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner J. Mol. Endocrinol., April 1, 2005; 34(2): 583 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Yang, D. Michod, J. Walicki, B. M. Murphy, S. Kasibhatla, S. J. Martin, and C. Widmann Partial Cleavage of RasGAP by Caspases Is Required for Cell Survival in Mild Stress Conditions Mol. Cell. Biol., December 1, 2004; 24(23): 10425 - 10436. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.C. dos Santos, B. Han, C.F. Andrade, X. Bai, S. Uhlig, R. Hubmayr, M. Tsang, M. Lodyga, S. Keshavjee, A.S. Slutsky, et al. DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNF{alpha}, LPS, and cyclic stretch Physiol Genomics, November 17, 2004; 19(3): 331 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishihara, M. Hwang, S. Kizaka-Kondoh, L. Eckmann, and P. A. Insel Cyclic AMP Promotes cAMP-responsive Element-binding Protein-dependent Induction of Cellular Inhibitor of Apoptosis Protein-2 and Suppresses Apoptosis of Colon Cancer Cells through ERK1/2 and p38 MAPK J. Biol. Chem., June 18, 2004; 279(25): 26176 - 26183. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Starenki, H. Namba, V. Saenko, A. Ohtsuru, and S. Yamashita Inhibition of Nuclear Factor-{kappa}B Cascade Potentiates the Effect of a Combination Treatment of Anaplastic Thyroid Cancer Cells J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 410 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rogatsky, J.-C. Wang, M. K. Derynck, D. F. Nonaka, D. B. Khodabakhsh, C. M. Haqq, B. D. Darimont, M. J. Garabedian, and K. R. Yamamoto Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor PNAS, November 25, 2003; 100(24): 13845 - 13850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. N. Wong, Y. Y. N. Tang, S. K. M. Lee, B. S. C. Fu, B. P. Chan, and C. K. M. Chan Effect of Dexamethasone on Cultured Human Tenocytes and Its Reversibility by Platelet-Derived Growth Factor J. Bone Joint Surg. Am., October 1, 2003; 85(10): 1914 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schafer, F. Sedehizade, T. Welte, and G. Reiser ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L376 - L385. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |